In Search for Reasons behind Helicobacter pylori Eradication Failure–Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species
暂无分享,去创建一个
M. Rajilić-Stojanović | D. Popadic | I. Gajić | T. Milosavljevic | Ana Bačić | D. Kekić | V. Milivojević | Isidora Petković | Branislava Medić Brkić
[1] F. Mégraud,et al. Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe , 2022, The American journal of gastroenterology.
[2] H. Tilg,et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report , 2022, Gut.
[3] Rui Xu,et al. Fungal Microbiota Dysbiosis and Ecological Alterations in Gastric Cancer , 2022, Frontiers in Microbiology.
[4] Song-Song Wang,et al. Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents , 2022, Infection and drug resistance.
[5] Ping Chen,et al. Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric Diseases , 2022, BioMed research international.
[6] Sixta L. Palencia,et al. Multiple surface interaction mechanisms direct the anchoring, co-aggregation and formation of dual-species biofilm between Candida albicans and Helicobacter pylori , 2021, Journal of advanced research.
[7] F. Mégraud,et al. Empirical second-line therapy in 5,000 patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) , 2021, Clinical Gastroenterology and Hepatology.
[8] M. Sugimoto,et al. Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis , 2021, Frontiers in Pharmacology.
[9] K. Sáez,et al. Temperatures Outside the Optimal Range for Helicobacter pylori Increase Its Harboring within Candida Yeast Cells , 2021, Biology.
[10] A. Fahim,et al. Candida colonization of the esophagus and gastric mucosa; a comparison of patients taking proton pump inhibitors and those taking histamine receptor antagonist drugs , 2021, Gastroenterology and hepatology from bed to bench.
[11] T. Hohl,et al. Mycobiota dysbiosis and gastric tumorigenesis , 2021, Theranostics.
[12] Y. Yamaoka,et al. Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications , 2021, Nature Reviews Gastroenterology & Hepatology.
[13] V. Campos,et al. Nutrient Deficiency Promotes the Entry of Helicobacter pylori Cells into Candida Yeast Cells , 2021, Biology.
[14] K. Sáez,et al. Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans ATCC10231 , 2021, Pathogens.
[15] E. El-Omar,et al. The interplay between Helicobacter pylori and gastrointestinal microbiota , 2021, Gut microbes.
[16] K. Sáez,et al. Intracellular Presence of Helicobacter pylori and Its Virulence-Associated Genotypes within the Vaginal Yeast of Term Pregnant Women , 2021, Microorganisms.
[17] Kimberly Sánchez-Alonzo,et al. Detection of Helicobacter pylori in oral yeasts from students of a Chilean university. , 2020, Revista da Associacao Medica Brasileira.
[18] J. Gisbert. Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review , 2020, Therapeutic advances in gastroenterology.
[19] F. Mégraud,et al. European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients , 2020, Gut.
[20] Yong Xie,et al. The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysis , 2020, Helicobacter.
[21] K. Sáez,et al. In Vitro Incorporation of Helicobacter pylori into Candida albicans Caused by Acidic pH Stress , 2020, Pathogens.
[22] J. Vítor,et al. Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches , 2020, Microbial genomics.
[23] J. Gisbert,et al. Systematic review: gastric microbiota in health and disease , 2020, Alimentary pharmacology & therapeutics.
[24] L. Kupčinskas,et al. Distinct composition and distribution of the gastric mycobiota observed between dyspeptic and gastric cancer patients evaluated from gastric biopsies , 2020 .
[25] Yunsheng Yang,et al. Mucosa microbiome of gastric lesions: Fungi and bacteria interactions. , 2020, Progress in molecular biology and translational science.
[26] M. Barone,et al. Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness , 2019, World journal of gastroenterology.
[27] I. Mitov,et al. Multidrug resistance in Helicobacter pylori: current state and future directions , 2019, Expert review of clinical pharmacology.
[28] N. Dash,et al. Exploring the impact of Helicobacter pylori on gut microbiome composition , 2019, PloS one.
[29] E. Touati,et al. Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection. , 2019, Advances in experimental medicine and biology.
[30] D. Graham,et al. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. , 2018, Gastroenterology.
[31] M. Leja,et al. Epidemiology of Helicobacter pylori infection , 2018, Helicobacter.
[32] A. Cancino. Candida sp. As a Potential Reservoir and Transmission Facilitator of Helicobacter Pylori , 2018 .
[33] S. Mshana,et al. The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: systematic review and meta-analysis , 2018, BMC Infectious Diseases.
[34] M. Upton,et al. High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR , 2018, Helicobacter.
[35] R. Alizadeh-Navaei,et al. Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection , 2018, Alimentary pharmacology & therapeutics.
[36] M. Ouellette,et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.
[37] S. Moss. The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer , 2016, Cellular and molecular gastroenterology and hepatology.
[38] Jiaqi Deng,et al. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.
[39] Antonio Gasbarrini,et al. Antibiotics as deep modulators of gut microbiota: between good and evil , 2016, Gut.
[40] F. Siavoshi,et al. The Effect of Helicobacter pylori Infection, Aging, and Consumption of Proton Pump Inhibitor on Fungal Colonization in the Stomach of Dyspeptic Patients , 2016, Front. Microbiol..
[41] G. Hung,et al. Development of Candida-Specific Real-Time PCR Assays for the Detection and Identification of Eight Medically Important Candida Species , 2016, Microbiology insights.
[42] Jason Y. Park,et al. Review article: the global emergence of Helicobacter pylori antibiotic resistance , 2015, Alimentary pharmacology & therapeutics.
[43] D. Scott,et al. Gastric Colonization by H. pylori , 2016 .
[44] H. E. Leylabadlo,et al. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. , 2015, World journal of methodology.
[45] A. Gasbarrini,et al. Gastric Microbiota , 2015, Helicobacter.
[46] P. Malfertheiner,et al. Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.
[47] G. Nardone,et al. The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? , 2015, United European gastroenterology journal.
[48] F. Siavoshi,et al. Vacuoles of Candida yeast as a specialized niche for Helicobacter pylori. , 2014, World journal of gastroenterology.
[49] R. Malekzadeh,et al. Localization of H.pylori within the vacuole of Candida yeast by direct immunofluorescence technique. , 2013, Archives of Iranian medicine.
[50] K. Sasaki. Candida-associated gastric ulcer relapsing in a different position with a different appearance. , 2012, World journal of gastroenterology.
[51] V. Young,et al. Interplay between the Gastric Bacterial Microbiota and Candida albicans during Postantibiotic Recolonization and Gastritis , 2011, Infection and Immunity.
[52] C. Hassan,et al. Mechanisms of Helicobacter pylori antibiotic resistance: An updated appraisal. , 2011, World journal of gastrointestinal pathophysiology.
[53] M. Zwolinska-Wcislo,et al. Assessment of co-existence of Helicobacter pylori and Candida fungi in diseases of the upper gastrointestinal tract. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[54] C. Hassan,et al. Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[55] M. Vieira,et al. Development and Application of a Novel Peptide Nucleic Acid Probe for the Specific Detection of Helicobacter pylori in Gastric Biopsy Specimens , 2007, Journal of Clinical Microbiology.
[56] R. Malekzadeh,et al. Antimicrobial effectiveness of ketoconazole against metronidazole-resistant Helicobacter pylori isolates from Iranian dyspeptic patients. , 2006, The Journal of antimicrobial chemotherapy.
[57] J. Stachura,et al. Fungal colonization of gastric mucosa and its clinical relevance. , 2001, Medical science monitor : international medical journal of experimental and clinical research.
[58] M. Blaser,et al. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. , 2001, Human pathology.
[59] R. Ansorg,et al. Adhesion of Helicobacter pylori to yeast cells. , 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[60] 中沢 俊二,et al. 胃疾患患者における Helicobacter pylori の検出状況 , 1996 .
[61] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[62] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.